Annual Total Long Term Liabilities
$4.16 M
-$300.10 K-6.72%
December 31, 2023
Summary
- As of February 8, 2025, IMRX annual total long term liabilities is $4.16 million, with the most recent change of -$300.10 thousand (-6.72%) on December 31, 2023.
- During the last 3 years, IMRX annual total long term liabilities has fallen by -$54.49 million (-92.90%).
- IMRX annual total long term liabilities is now -92.90% below its all-time high of $58.65 million, reached on December 31, 2020.
Performance
IMRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$3.92 M
-$84.30 K-2.11%
September 30, 2024
Summary
- As of February 8, 2025, IMRX quarterly total long term liabilities is $3.92 million, with the most recent change of -$84.30 thousand (-2.11%) on September 30, 2024.
- Over the past year, IMRX quarterly long term liabilities has dropped by -$166.40 thousand (-4.08%).
- IMRX quarterly long term liabilities is now -95.30% below its all-time high of $83.40 million, reached on June 30, 2021.
Performance
IMRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
IMRX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.7% | -4.1% |
| 3 y3 years | -92.9% | -12.3% |
| 5 y5 years | -79.3% | -12.3% |
IMRX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.2% | at low | -23.1% | at low |
| 5 y | 5-year | -92.9% | at low | -95.3% | +712.5% |
| alltime | all time | -92.9% | at low | -95.3% | +712.5% |
Immuneering Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.92 M(-2.1%) |
| Jun 2024 | - | $4.00 M(-2.0%) |
| Mar 2024 | - | $4.08 M(-1.9%) |
| Dec 2023 | $4.16 M(-6.7%) | $4.16 M(-1.8%) |
| Sep 2023 | - | $4.24 M(-1.6%) |
| Jun 2023 | - | $4.31 M(-1.6%) |
| Mar 2023 | - | $4.38 M(-1.8%) |
| Dec 2022 | $4.46 M | $4.46 M(-1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $4.54 M(-2.4%) |
| Jun 2022 | - | $4.65 M(-1.3%) |
| Mar 2022 | - | $4.72 M(-7.3%) |
| Dec 2021 | $5.09 M(-91.3%) | $5.09 M(+956.2%) |
| Sep 2021 | - | $482.00 K(-99.4%) |
| Jun 2021 | - | $83.40 M(>+9900.0%) |
| Mar 2021 | - | $524.10 K(-99.1%) |
| Dec 2020 | $58.65 M(+191.5%) | $58.65 M |
| Dec 2019 | $20.12 M | - |
FAQ
- What is Immuneering annual total long term liabilities?
- What is the all time high annual total long term liabilities for Immuneering?
- What is Immuneering annual total long term liabilities year-on-year change?
- What is Immuneering quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Immuneering?
- What is Immuneering quarterly long term liabilities year-on-year change?
What is Immuneering annual total long term liabilities?
The current annual total long term liabilities of IMRX is $4.16 M
What is the all time high annual total long term liabilities for Immuneering?
Immuneering all-time high annual total long term liabilities is $58.65 M
What is Immuneering annual total long term liabilities year-on-year change?
Over the past year, IMRX annual total long term liabilities has changed by -$300.10 K (-6.72%)
What is Immuneering quarterly total long term liabilities?
The current quarterly long term liabilities of IMRX is $3.92 M
What is the all time high quarterly long term liabilities for Immuneering?
Immuneering all-time high quarterly total long term liabilities is $83.40 M
What is Immuneering quarterly long term liabilities year-on-year change?
Over the past year, IMRX quarterly total long term liabilities has changed by -$166.40 K (-4.08%)